Journal
MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 16, Issue 11, Pages 872-891Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557516666151120115947
Keywords
Anticancer; Drugs-macrocyclic compounds system; Nanoparticle drug system; Platinum-based drugs; Polymer-drug system; Review; Targeted drug delivery system
Categories
Funding
- National Natural Science Foundation of China [21361014, 21302074, 21062009]
- Doctoral Fund of Ministry of Education Fund [20125314120007]
- Natural Science Foundation of Yunnan Province [KKSY201226108]
Ask authors/readers for more resources
Platinum-based (Pt-based) anticancer drugs have been recognised as one of the most effective drugs for clinical treatment of malignant tumors due to its unique mechanism of action and broad range of anticancer spectrum. But, there are still some limitations such as side effects, drug resistance/cross resistance, no-specific targeting, becoming obstacles to restrict its expanding of clinical application. Targeted drug delivery system (TDDS) is a promising strategy for the research of novel Pt-based anticancer drugs. A variety of TDDS have been explored to improve the antitumor activity of Pt-based drugs such as nanoparticle drug systems, polymer-drug systems, drugs-macrocyclic compounds systems, etc. The review concentrates on recent development of various targeted drug delivery techniques, which could provide more opportunities for the development of Pt-based drugs with better efficiency, lower toxicity and less resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available